Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Aberrant Non-Homologous End Joining in Multiple Myeloma: A Role in Genomic Instability and As Potential Prognostic Marker.

Blood (2012) 120 (21): 2932.

https://doi.org/10.1182/blood.V120.21.2932.2932

Published: 2012

Journal Articles

Multiple Myeloma-Derived Bone-Marrow Mesenchymal Stem Cells: Microrna-, Gene Expression-Profiling and Functional Characterization

Michaela R Reagan, PhD, Aldo M Roccaro, MD, PhD, AbdelKareem Azab, PhD, Yong Zhang, PhD, Grace B O'Callaghan, PhD, Patricia Maiso, PhD, Salomon Manier, MD, David L. Kaplan, PhD, Irene M. Ghobrial, MD

Blood (2012) 120 (21): 1837.

https://doi.org/10.1182/blood.V120.21.1837.1837

Published: 2012

Journal Articles

L-Stereoisomer RNA Oligonucleotide Anti-SDF-1 (Nox-A12) Disrupts the Interaction of Multiple Myeloma Cells with the Bone Marrow Milieu In Vivo , Leading to Enhanced Sensitivity to Bortezomib

Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Phong Quang, BS, AbdelKareem Azab, PhD, Patricia Maiso, PhD, Feda Azab, BPharm, Yong Zhang, PhD, Ghayas C Issa, MD, Yang Liu, PhD, Hai T Ngo, BS, Anna Kruschinski, PhD, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 887.

https://doi.org/10.1182/blood.V118.21.887.887

Published: 2011

Journal Articles

The New CXCR4 Inhibitor MDX-1338 Exerts Anti-Tumor Activity in Multiple Myeloma

Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Michelle Kuhne, PhD, AbdelKareem Azab, PhD, Patricia Maiso, PhD, Yong Zhang, PhD, Yang Liu, PhD, Feda Azab, BPharm, Ghayas C Issa, MD, Phong Quang, BS, Hai T Ngo, BS, Chin Pan, Ph.D., Lew Choen, PhD, Pina M Cardarelli, Ph.D., Irene M. Ghobrial, MD

Blood (2011) 118 (21): 1844.

https://doi.org/10.1182/blood.V118.21.1844.1844

Published: 2011

Journal Articles

Dual Targeting of -TORC1 and -TORC2 as a New Strategy In the Treatment of Multiple Myeloma

Patricia Maiso, PhD, AbdelKareem Azab, PhD, Yang Liu, PhD, Yong Zhang, PhD, Feda Azab, Antonio Sacco, Hai T Ngo, Yi Liu, PhD, Brittany Morgan, Christian Rommel, PhD, Kenneth C. Anderson, MD, Aldo M. Roccaro, MD, PhD, Irene M. Ghobrial, MD

Blood (2010) 116 (21): 133.

https://doi.org/10.1182/blood.V116.21.133.133

Published: 2010

Journal Articles

PKC412, a Small Molecule Tyrosine Kinase Inhibitor, Regulates Survival and Proliferation Pathways in Waldenström Macroglobulinemia

Molly R. Melhem, Aldo M. Roccaro, Abdelkareem Azab, Hai T. Ngo, Antonio Sacco, Xiaoying Jia, Feda Azab, Judith Runnels, Nicolas Burwick, Phong Quang, Emanuel N. Husu, Xavier Leleu, Kenneth C. Anderson, Irene M. Ghobrial

Blood (2008) 112 (11): 2614.

https://doi.org/10.1182/blood.V112.11.2614.2614

Published: 2008

Journal Articles

Targeting NF-κB in Waldenstrom macroglobulinemia

Blood (2008) 111 (10): 5068–5077.

https://doi.org/10.1182/blood-2007-09-115170

Published: 2008

Journal Articles

Dual targeting of the proteasome regulates survival and homing in Waldenström macroglobulinemia

Aldo M. Roccaro, Xavier Leleu, Antonio Sacco, Xiaoying Jia, Molly Melhem, Anne-Sophie Moreau, Hai T. Ngo, Judith Runnels, Abdelkareem Azab, Feda Azab, Nicholas Burwick, Mena Farag, Steven P. Treon, Michael A. Palladino, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson, Irene M. Ghobrial

Blood (2008) 111 (9): 4752–4763.

https://doi.org/10.1182/blood-2007-11-120972

Published: 2008

Includes: Supplemental data

Journal Articles

The Interaction of CXCR4/SDF-1 and VLA-4 Regulates Adhesion and Transendothelial Migration in Waldenstrom Macroglobulinemia.

Hai T. Ngo, Mena Farag, Xavier Leleu, Xiaoying Jia, Judith Runnels, Anne-Sophie Moreau, Abdelkareem Azab, Feda Azab, Evdoxia Hatjiharissi, Aldo Roccaro, Antonio Sacco, Irene M. Ghobrial

Blood (2007) 110 (11): 2617.

https://doi.org/10.1182/blood.V110.11.2617.2617

Published: 2007

Journal Articles

In Vivo Mobilization of Multiple Myeloma Cells Out of the Bone Marrow Using the CXCR4 Inhibitor AMD3100 and Bortezomib: Implications for Sensitization of Myeloma Cells to Apoptosis.

Judith M. Runnels, Abdelkareem Azab, Costas Pitsillides, Anne-Sophie Moreau, Feda Azab, Joel A. Spencer, Xavier Leleu, Alicia L. Carlson, Beatriz E. Ospina, Renee Wright, Xiaoying Jia, Hai Ngo, Andrew L. Kung, Charles P. Lin, Irene M. Ghobrial

Blood (2007) 110 (11): 2501.

https://doi.org/10.1182/blood.V110.11.2501.2501

Published: 2007

Journal Articles

Targeting NF-kB by Perifosine, Bortezomib and Rituximab in Waldenstrom Macroglobulinemia (WM).

Xavier Leleu, MD, Eeckhoute Jerome, PhD, Xiaoying Jia, Anne-Sophie Moreau, MD, Aldo M. Roccaro, MD, Mena Farag, Antonio Sacco, Evdoxia Hatjiharissi, MD, Hai T. Ngo, Judith Runnels, PhD, Abdelkareem Azab, PhD, Feda Azab, Zachary Hunter, Peter Sportelli, Steven P. Treon, MD, Teru Hideshima, MD, Kenneth C. Anderson, MD, Irene M. Ghobrial, MD

Blood (2007) 110 (11): 2512.

https://doi.org/10.1182/blood.V110.11.2512.2512

Published: 2007

Journal Articles

The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).

Aldo Roccaro, MD, Xavier Leleu, MD, Antonio Sacco, Xiaoying Jia, Anne-Sophie Moreau, MD, Hai Ngo, Abdelkareem Azab, Feda Azab, Evdoxia Hatjiharissi, MD, Steven Treon, MD, Teru Hideshima, MD, Michael Palladino, Kenneth Anderson, MD, Dharminder Chuahan, Irene Ghobrial, MD

Blood (2007) 110 (11): 1516.

https://doi.org/10.1182/blood.V110.11.1516.1516

Published: 2007

Journal Articles

Regulation of the New CXCR7 Receptor in Plasma Cell Dyscrasias.

Anne-Sophie Moreau, MD, Xavier Leleu, MD, Xiaoying Jia, Judith Runnels, PhD, Costas Pitsillides, Alicia L. Carlson, PhD, Hai T. Ngo, Aldo M. Roccaro, MD, Abdelkareem Azab, PhD, Feda Azab, Charles P. Lin, PhD, Irene M. Ghobrial, MD

Blood (2007) 110 (11): 3527.

https://doi.org/10.1182/blood.V110.11.3527.3527

Published: 2007

NARROW

Aberrant Non-Homologous End Joining in Multiple Myeloma: A Role in Genomic Instability and As Potential Prognostic Marker.

Multiple Myeloma-Derived Bone-Marrow Mesenchymal Stem Cells: Microrna-, Gene Expression-Profiling and Functional Characterization

L-Stereoisomer RNA Oligonucleotide Anti-SDF-1 (Nox-A12) Disrupts the Interaction of Multiple Myeloma Cells with the Bone Marrow Milieu In Vivo , Leading to Enhanced Sensitivity to Bortezomib

The New CXCR4 Inhibitor MDX-1338 Exerts Anti-Tumor Activity in Multiple Myeloma

Dual Targeting of -TORC1 and -TORC2 as a New Strategy In the Treatment of Multiple Myeloma

PKC412, a Small Molecule Tyrosine Kinase Inhibitor, Regulates Survival and Proliferation Pathways in Waldenström Macroglobulinemia

Targeting NF-κB in Waldenstrom macroglobulinemia

Dual targeting of the proteasome regulates survival and homing in Waldenström macroglobulinemia

The Interaction of CXCR4/SDF-1 and VLA-4 Regulates Adhesion and Transendothelial Migration in Waldenstrom Macroglobulinemia.

In Vivo Mobilization of Multiple Myeloma Cells Out of the Bone Marrow Using the CXCR4 Inhibitor AMD3100 and Bortezomib: Implications for Sensitization of Myeloma Cells to Apoptosis.

Targeting NF-kB by Perifosine, Bortezomib and Rituximab in Waldenstrom Macroglobulinemia (WM).

The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).

Regulation of the New CXCR7 Receptor in Plasma Cell Dyscrasias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only